INTERNATIONAL PATENT: QURE BIOTECHNOLOGY (SHANGHAI) CO., LTD., 启愈生物技术（上海）有限公司 FILES APPLICATION FOR "CD80/TAA FUSION PROTEIN ASSOCIATED TUMOR TARGETING, T CELL ACTIVATION MOLECULE FORM AND USE THEREOF"

Posted On: 2025-08-17

GENEVA, Aug. 17 -- QURE BIOTECHNOLOGY (SHANGHAI) CO., LTD. (Room 204, Room 206, Room 207, 2nd Floor, Incubation Building, No. 1118 Halei Road, No. 1227 Zhang Heng Road, Free Trade Pilot ZonePudong New Area, Shanghai 201203), 启愈生物技术（上海）有限公司 (中国上海市浦东新区自由贸易试验区张衡路1227号、哈雷路1118号孵化楼第二层204室、206室、207室) filed a patent application (PCT/CN2024/141427) for "CD80/TAA FUSION PROTEIN ASSOCIATED TUMOR TARGETING, ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: QURE BIOTECHNOLOGY (SHANGHAI) CO., LTD., 启愈生物技术（上海）有限公司 FILES APPLICATION FOR "CD80/TAA FUSION PROTEIN ASSOCIATED TUMOR TARGETING, T CELL ACTIVATION MOLECULE FORM AND USE THEREOF"